Cyberonics and Sorin have merged and are now LivaNova. Information found here may no longer be correct or up-to-date; please visit www.livanova.com for the most current information. Your continued use of our website constitutes understanding and acceptance of these changes.
Day High: 70.25
Day Low: 68.66
4:00 PM ET Oct 16, 2015
Delayed at least 20 min., by eSignal.
Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Cyberonics, Inc.'s financial performance into perspective.